In hepatocellular carcinomas, Beclin1 was increased compared to normal and reduction in Beclin1 was reported as predictor of disease free survival and aggressive cancers had low levels of Beclin1 [83]; the findings in liver cancer could suggest less aggressive cancers. This evidence concerns the gene BECN1 and hepatocellular carcinoma.